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This chapter explores the reasoning behind using the vaccination model to examine the influence 
of psychosocial factors on immunity.  It then briefly discusses the mechanics of the vaccination 
response and the protocols used in Psychoneuroimmunology vaccine research, before giving 
examples from the research literature of the studies examining relationships such as the 
association between stress and the vaccination response.  It also explores the ways the 
vaccination model can be used to answer key questions in Psychoneuroimmunology, such as: 
does it matter when stressful life events occur relative to when the vaccine is received?’ ‘what 
are the effects of prior exposure to the antigen?’ and ‘do other psychosocial factors influence 
vaccine response besides stress?’  Finally, it briefly considers the mechanisms underlying 
psychosocial factors and vaccination response associations and the future research needed to 
understand these better, and indeed to use current and future knowledge to improve and enhance 
vaccine responses in key at risk populations. 
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1. Introduction: Why study vaccination in the context of PNI research? 
1.1 Alternative approaches: enumerative measures 
There are many methods for examining the effects of psychological factors on immunity.  Early 
work concentrated on the influence of psychosocial stress on enumerative measures of immunity.  
For example, individuals exposed to chronic stress showed reduced numbers of certain immune 
cells including reduced numbers of B-lymphocytes (1,2), helper T-lymphocytes (3,4,1), 
 
 
cytotoxic T-lymphocytes (5,1), natural killer (NK) cells (5,1) and lowered concentrations of 
secretory immunoglobulin A in saliva (6-10), compared to matched controls.  However, it is 
difficult to determine the clinical significance of such enumerative changes, given that they lie 
within the normal range for healthy participants (11) and may simply reflect cell migration and 
recirculation rather than increased production or better function (11).  Additionally, cell number 
changes could be a consequence of shifts in plasma volume and haemoconcentration; in such 
circumstances, changes in cell number would reflect increased density of a lymphocyte 
population rather than signal a true increase in absolute cell numbers.  Further, even absolute 
changes in cell number might not necessarily reflect alteration in the capacity of the immune 
system to mount an effective response to antigenic challenge (11).  Consequently, measuring 
changes in cell number is perhaps not the optimal means of determining variations in the 
functional capacity of the immune system, and hence the likely clinical implications of 
psychosocial variables for disease resistance and susceptibility. 
 
1.2 In vitro measures 
In vitro measures of immune function, such as cell proliferation to stimulation with an antigen 
(foreign material e.g. bacteria), or cell cytotoxicity (killing ability), have been argued to provide 
a better indication of the functional capacity of the immune system (11).  These measures have 
been demonstrated to be susceptible to impairment by chronic stress in many studies, e.g., (12-
15).  For example, recently unemployed individuals showed poorer lymphocyte proliferation to 
antigen than those in employment (16).  Further, compared to non-bereaved controls, individuals 
who have suffered bereavement showed lower neutrophil superoxide production, one of their key 
 
 
cytotoxic capacities through which they eradicate bacteria such as pneumonia (17).  
Nevertheless, the isolated testing of any particular network of immune cells provides only 
limited information about the overall status of what is a highly integrated and complex system 
(11), and an imperfect understanding of the relationship between psychosocial factors and 
vulnerability to disease (18).  
 
2. The vaccination model 
2.1 Benefits of the vaccination model 
A clinically relevant model which examines the impact of psychosocial factors on the integrated 
response of the immune system to a challenge would avoid these disadvantages.  The antibody 
response to vaccination provides us with such a model.  Vaccines act as real immune system 
challenges, although they are altered in such a way so not to induce disease either by being 
inactivated or killed, or only a component of the actual pathogen, so are really ‘imitation 
infections’.  Therefore, by measuring the antibody levels in response to vaccination we can 
assess directly how well the immune system responds to infectious challenge.  It is also clinically 
relevant in that antibody levels or titres are directly related to susceptibility and resistance to 
infectious disease. 
  
2.2 The vaccination response 
The vaccination response involves the coordination of a wide variety of immune cells.  Antigen 
is initially recognized and presented by professional antigen presenting cells, such as dendritic 
 
 
cells.  Thus presented, the antigen is then recognised by specific helper T cells which process and 
present the antigen to B-cells, the antibody factories of the immune system; this is termed a 
thymus-dependent response.  There are other types of vaccination which are also recognized by 
B-cells without the necessity for T-cell help, thus termed a thymus-independent response, which 
do not elicit as strong or maintained a response as thymus-dependent vaccines.  A final type of 
vaccination, called a conjugate vaccination, is used to improve the response to thymus-
independent antigens by attaching a protein to the antigen, which then stimulates an immune 
response involving helper T-cell recognition. 
 
When stimulated by an antigen, B-lymphocytes replicate and mature into short lived plasma cells 
which produce the earliest antibody or immunoglobulin, IgM.  In a primary response to an 
antigen not previously encountered, the peak IgM response occurs around five days after 
vaccination.  Interaction between activated T- and B-cells leads to the production of high affinity 
or very specific antibodies in bodily fluids: IgG (found mainly in the blood) and IgA (found 
mainly at mucosal surfaces, e.g. in saliva).  This more specific response peaks around 28 days 
after vaccination.  Other types of antibody include IgE (part of the allergic response) and IgD.  
IgG is particularly important, as being the most prolific antigen in the blood and a more specific 
match to the particular antigen makes it more effective at antigen elimination.  Secondary 
antibody responses, in which the immune system has been previously exposed to the antigen, are 
more rapid and of greater magnitude; this is because some activated T- and B-cells become long 
lived resting memory cells, remaining in the immune system ready to respond quickly to 
challenge with previously encountered antigens.  Part of the response to vaccination is also cell-
mediated as well as humoral (involving antibodies) such that helper T-cells are also activated and  
 
 
initiate production of key pro-inflammatory cytokines, including IL-1β, IL-6, and IL-8, in 
response to vaccine antigens, which can also be measured quantitatively as part of the 
vaccination response, although is less commonly done so.  
 
Not all individuals react with a strong antibody response to vaccination, particularly older adults 
who are only protected against influenza disease in 30-50% of cases following vaccination (19-
22).  Further, the increase in vaccination availability has not been paralleled by decreased 
influenza-related mortality (23).  This variation in the vaccination response allows for the 
investigation of other factors which might influence this aspect of immunity between individuals.  
The relevance of the response to infectious disease risk provides the clinically relevant 
imperative to do so beyond the interest in increasing knowledge on how various factors affect 
immune function.  As well as age, psychosocial factors, such as stress, may alter both the 
quantity and quality of antibody present at different times after immunization, meaning that 
individuals suffering higher levels of stress are more at risk of infectious disease.   
 
3. Stress and the vaccination response 
3.1 Stress questionnaires 
The most common psychosocial factor examined in the context of the vaccination response is 
stress.  This is usually assessed via life events checklists or perceived stress measures.  Life 
events checklists consist of a list of major and minor life events, e.g. bereavement, moving 
house, and usually require participants to indicate which have occurred during the past month or 
 
 
year (24).  Some also ask participants to indicate how stressful each event was on a rating scale.  
Life events have been shown to predict a variety of important physical health outcomes, 
including infectious disease (25), and mortality, particularly in the context of little emotional 
support (26).  In contrast, perceived stress scales measure individuals’ feelings about how 
stressful their lives are rather than the direct occurrence of events (27).  Thus these measures are 
more susceptible to subjective bias, and are better predictors of subjective health outcomes, such 
as angina, rather than objective outcomes, such as myocardial infarction (28).   
 
3.2 Caregiver control models 
Another common way of assessing stress in the context of vaccination is to examine antibody 
responses among those with a key chronic stressor versus a socio-demographically matched 
control group, for example, older adults caregiving for a spouse with dementia.  The stress of 
caregiving has been shown to relate to poor health and mortality (29), and can thus be considered 
an important source of ongoing psychological stress.  Other stress studies compare matched 
controls to other groups subject to chronic stressors such as bereavement, marital 
separation/divorce, or unemployment. 
 
3.3 Protocol for stress and vaccination studies 
In order to fully test the impact of psychosocial factors on the response to vaccination, both pre-
vaccination and post-vaccination blood samples are required for assessment of antibody levels.  
This is due to the impact that prior vaccination or environmental exposure to the infectious agent 
 
 
can have on pre-vaccination antibody levels, and consequently post-vaccination levels.  Without 
taking a pre-vaccination baseline, it is difficult to state whether stress is affecting the antibody 
response to a vaccination administered during a research study or simply on the maintenance of 
previous antibody levels.  For example, in 37 nursing home residents, those who reported higher 
levels of perceived stress had lower pre-vaccine antibody titres to two influenza vaccine 
components (30).  However, it is not clear what this means, given that pre-vaccine titres could 
reflect differences in prior vaccine history or exposure.  In this same study, social support was 
also negatively correlated with pre- and post-vaccination titres against the A/Panama influenza 
strain yet positively with pre-vaccination antibody titres against the A/New Caledonia strain 
(30), making interpretation of the findings very difficult.  However, some of the early studies of 
stress and vaccination in students were opportunistic, in other words they collected stress data 
from students who opportunistically had already received a prior vaccination.  Although more 
complex to interpret, given lack of baseline or prior exposure information, these studies are able 
to show that psychological stress does seem to affect the maintenance of antibody titres over 
time.  For example, one study examined the association between life events stress and hepatitis B 
antibody titre in medical students, vaccinated either in the past twelve months or at least thirteen 
months previously (31).  Whereas life events exposure was not related to antibody response in 
the recently vaccinated cohort, participants in the earlier vaccinated cohort who reported higher 
life events over the past year were over twice as likely to show an inadequate antibody titre as 
those with lower life events exposure, providing some evidence that psychosocial stress can have 
effects on the rate of deterioration of antibody protection (31).  Similarly, the maintenance of 
higher antibody levels after the conjugate meningococcal C vaccination was associated with 




3.4 Key stress and vaccination findings 
One of the most common vaccinations studied in the context of stress and antibody response is 
the influenza vaccination, particularly in undergraduate student and older caregiver samples.  
The influenza vaccination is a commonly utilised vaccine and consists of three components or 
strains, usually two A strains and one B strain, which change each year depending on the key 
circulating varieties.  A meta-analysis of 13 studies of psychological stress and influenza 
vaccination concluded that there is a significant negative relationship between psychological 
stress and antibody titre following influenza vaccination (33).  These studies included five in 
caregivers and eight assessing the impact of stressful life events or perceived stress.  The meta-
analysis concluded that psychological stress, however measured, had a similar negative impact 
on influenza vaccine response, but that antibody responses to A/H1N1 and B-influenza types 
were more sensitive to the influence of stress (33).  However, it is difficult at this stage to explain 
why antibodies against influenza strains are differentially associated with stress.  One possibility 
is that strain novelty influences the associations observed (34,11), with more novel strains being 
more susceptible to stress effects.   
 
The impact on certain A-strains and on B-strains is clearly shown in several studies of students.  
For example, those reporting higher stressful life event exposures and/or higher perceived stress 
prior to vaccination showed poorer responses to the A-strains of the vaccine at five weeks 
(around the time of the peak response) and five months post-vaccination (indicating the decay in 
antibody response over time) (35).  This was replicated for the numbers and severity of stressful 
 
 
life events prior to vaccination with the response to the B/Shandong influenza strain at both five 
weeks and five months post-vaccination (36).  Similarly, in a study of the effects of daily stress 
and feelings of being overwhelmed during the 10 days following vaccination, higher stress 
ratings were associated with lower antibody titres to the A/New Caledonia strain at both one and 
four months following vaccination (37).  In older adults too, we observed that the stress of 
bereavement in the year prior to influenza vaccination was associated with a poorer antibody 
response to two of the influenza strains in a community sample of 184 adults aged 65 and over 
(38).  Overall negative life events exposure was not associated with vaccine response in this 
study, as has similarly been found for self-reported stress in another study of the influenza 
vaccination in older adults, although only one item was used to assess stress (39).  However, the 
effect found above for bereavement suggests that stressful events are related to pervasive 
immune effects throughout the life course, although what constitutes life events stress will vary 
depending on the age of the sample studied.  Taken together, these studies provide evidence that 
stressful life events both preceding and in the period immediately following vaccination can 
influence the antibody response.  They also show that both the peak antibody response at around 
four weeks and the decay in antibody protection over time are susceptible to influence by 
stressful life events.  
 
Interestingly, in the majority of these studies, where measured, self-reported or perceived stress 
has not been associated with the antibody response to vaccination, whereas the occurrence of 
stressful life events has.  This suggests that actual stressful events occurrence is more detrimental 
than individuals’ perceptions of stress, which may more closely reflect individual differences in 




On the whole, the vaccination response in older adults has mainly been considered in the context 
of the chronic stress of caregiving for a spouse with dementia.  Studies have shown that 
caregivers have poorer antibody responses to vaccination in comparison to matched control 
participants (40-42).  Similarly, caregivers who exhibited repetitive negative thoughts about their 
situation had lower antibody titres following influenza vaccination (43).  More recently, in a 
study in Hong Kong, older caregivers had significantly lower cell-mediated but not humoral 
(antibody) responses to the influenza vaccination at 12 weeks compared to non-caregivers (44).  
However, in younger populations, such as Multiple Sclerosis spousal caregivers, there was no 
difference in antibody response to influenza vaccination between caregivers and controls (45).  
This raises the issue of whether the poor antibody response observed in older caregivers is, to an 
extent, a function of an interaction between chronic stress exposure and immunosenescence (46).   
 
There is an alternative explanation for the discrepancy in outcomes among the caregiver 
vaccination studies.  Rather than immune ageing, perhaps it is the intensity of the stress 
experienced that determines whether caregiving becomes an issue for immunity (45).  
Dementia is a disease characterised by much more severe cognitive and behavioural 
disturbances than multiple sclerosis (47-50), and older spousal caregivers of dementia 
patients have been found to report greater distress than younger multiple sclerosis caregivers 
(45).  Further, the results of two recent meta-analyses indicate that caregivers of dementia 
patients generally experience greater burden and report more symptoms of depression than 
those caring for non-dementia, e.g., cancer, patients, (51,52).  Thus, it might be 
 
 
hypothesized that, irrespective of the caregiver’s age, caring for someone with severe 
cognitive and behavioural problems will compromise immunity.   
 
We have been able to test this hypothesis recently using a caregiving model in younger adults; 
young parents caring for children with developmental disabilities.  Dealing with severe 
cognitive difficulties and behaviours that are problematic and distressing are the main 
challenges of such caring (53-56).  In our own studies of 30 caregivers for a child with a 
developmental disability (mainly Autism) versus matched controls, we have demonstrated that 
caregivers report high levels of stress, anxiety, depression, child problem behaviours, and low 
levels of social support.  These caregivers also exhibited a poorer antibody response to a 
pneumonia vaccination than parents caring for typically developing children at both one and 
six months post-vaccination (57).  Of the psychological variables considered, child problem 
behaviours mediated this effect.  In addition, within the caregivers, parents reporting more 
child conduct problems, a component of the child problem behaviour measure, mounted a 
poorer antibody response at 1-month than parents reporting less conduct problems (57).   
Similarly, these parents mounted a poorer antibody response to the B/Malaysia strain of an 
influenza vaccine at one and six months post-vaccination, which again appeared to be 
mediated by differences in child problem behaviours (58).   
 
These recent findings in younger caregivers reinforce the hypothesis that an ageing immune 
system is not a pre-requisite for a poor response to medical vaccination in caregivers.  
Nevertheless, among our parental caregivers, older caregivers tended to have a poorer 
 
 
antibody response to B/Malaysia at 1-month, suggesting that we cannot dismiss the hypothesis 
that chronic stress and immunosenescence may have synergistic effects (46).    
 
4. Different vaccine factors 
Vaccination studies also have the advantage of being able to incorporate research questions such 
as ‘does it matter when stressful life events occur relative to when the vaccine is received?’ and   
‘what are the effects of prior exposure to the antigen?’ The next section of this chapter will 
address some of these issues of timing. 
 
4.1 Timing of stress measurement 
This issue of the timing of stress assessment has been developed in studies of various 
vaccinations including hepatitis B, which is useful in this context, as the vaccination schedule 
consists of three inoculations over a six month period.  The largest of these studies examined the 
association between life events stress and the final antibody titre in students, vaccinated either in 
the past twelve months or at least thirteen months previously (31).  Whereas life events exposure 
was not related to antibody response in the recently vaccinated cohort, participants in the earlier 
vaccinated cohort who reported higher life events over the past year were over twice as likely to 
show an inadequate antibody titre as those with lower life events exposure.  This finding 
suggests that the immunogenicity, the ability to induce a strong vaccination response, of hepatitis 
B vaccination may initially override the influence of life events stress, although there was also 
more power to detect effects in the earlier vaccinated cohort as more participants exhibited 
 
 
inadequate antibody titres (31).  Nevertheless, this study provides some evidence that 
psychosocial stress in the period following vaccination can have effects on the rate of 
deterioration of antibody protection (18). 
 
In a study where a low dose of hepatitis B vaccine was administered, a higher stress index, 
comprising life events exposure and psychological symptoms, measured at two months post-
vaccination (thus considering the period post-vaccination) was associated with a poorer final six 
month antibody response, and the stress index at six months also tended to relate negatively to 
antibody response (59).  However, as only the final antibody titre was measured, it is difficult to 
determine whether, in this instance, stress predominantly influenced initial formation or 
maintenance of antibody levels.  Also, the inclusion of psychological symptoms in the composite 
stress index makes it difficult to ascribe this finding to any specific aspect of stress (18).  A 
similar study using the full dosage hepatitis B vaccination did not yield any significant stress 
effects (60), although it is possible that this was due to the absence of a two-month assessment of 
stress, which was the main predictor of antibody response in the previous study by this group.  In 
a study measuring perceived stress and anxiety during the vaccination period, i.e. post-
vaccination, these were not associated with the final antibody response to hepatitis B (40).  
Further, life events stress prior to vaccination and perceived stress at the time of the initial 
vaccination were not related to antibody status five months following the initial inoculation in a 
more recent study (61).  On the whole, this would suggest either that stress prior to vaccination is 
less detrimental to the antibody response than stress post-vaccination, or that it is difficult to 
observe stress effects early on with the full dose hepatitis B vaccination, due to its 
 
 
immunogenicity.  Given the findings with the influenza vaccination and stress, this latter seems 
the more likely explanation.   
 
In contrast to the studies of hepatitis B discussed thus far, one study reported a positive 
association between perceived life event stress, depression and anxiety during the vaccination 
period and hepatitis B antibody status nine months following the initial vaccination (62).  This 
anomalous result has been attributed to the relatively low levels of stress experienced by the 
participants in this study, suggesting that moderate levels of life change stress experienced 
during the initial stages of antibody formation may be beneficial to the antibody response, 
although high levels may be detrimental (62).  Such an interpretation receives support from 
animal research where moderate stress at the time of vaccination has been associated with an 
enhanced antibody response (see e.g. (63).  This will be discussed further in the section on acute 
stress below. 
 
4.2 Primary and secondary exposure to vaccine antigens 
Vaccination with an antigen to which the participant has not been previously exposed induces a 
primary antibody response whereas vaccination against more common pathogens such as 
influenza, induce a secondary immune response.  By examining the effect of stress on both 
primary and secondary immune responses, we can begin to determine which aspects of the 




Hepatitis B vaccination has been used in this context due to the vaccination schedule and the low 
likelihood of prior naturalistic exposure to this pathogen.  In an earlier study, individuals 
reporting higher mean perceived stress and anxiety over the vaccination period were less likely 
to have sero-converted (produced a protective antibody level) by the time of the second 
inoculation (40).  Whereas, an emotional disclosure intervention group did not differ from 
controls in antibody levels at the time of the second inoculation (64).  However, psychological 
stress levels were not measured, making it difficult to interpret these data.  More recently, we 
have used hepatitis A as a primary antigen.  Students who reported a higher number and severity 
of life events had a poorer antibody response to hepatitis A at the 18-week, but not 4-week, 
follow-up, suggesting stress can impact upon the maintenance of antibody levels (65).  Early 
studies using the vaccination model used novel non-pathogenic antigens to examine the antigen-
specific antibody response.  Keyhole limpet hemocyanin (KLH), a protein, has been used in this 
context; the KLH-specific IgG antibody response was lower at eight weeks, but not three weeks, 
post-vaccination in participants reporting fewer positive life events prior to vaccination (66).   
 
The consensus of this evidence suggests that stress can influence the primary antibody response, 
particularly the maintenance of responses to novel antigens.  It also supports the idea that life 
events stress effects are more likely to be evident with novel vaccine types (36).  As discussed 
above, the secondary antibody response to hepatitis B vaccination has produced mixed results, 
but there appears to be stronger evidence for a negative effect of psychological stress on the 




4.3 Thymus-dependent versus thymus-independent vaccines 
A further advantage to the vaccination model is that there are different types of vaccination, 
which can be used to help elucidate which cells involved in the vaccination response are 
influenced by psychological factors.  Most vaccinations, which consist of inactivated or dead 
viruses like influenza, induce a thymus-dependent antibody response, as described above.  A few 
vaccinations, however, protect against bacterial infections or toxins, like meningococcal A or 
tetanus, respectively, which do not require T-cell help.  There are also conjugate vaccines, in 
which substances that elicit a T-cell response are conjugated to a thymus-independent pathogen, 
such as a protein, in order to boost the efficiency of the antibody response against the thymus-
independent pathogen.  If psychological factors are consistently associated with the response to 
thymus-dependent and conjugate vaccinations but not with thymus-independent response, this 
would imply that it is T-cells that are particularly liable to psychological influence.   
 
Indeed, there is evidence to suggest that stress may exert its effects mainly on T-cells; we 
showed that higher frequency and intensity of stressful life events were associated with a poorer 
response to influenza and meningococcal C (following previous conjugate meningococcal C 
vaccination), but not to thymus-independent meningococcal A (36).  Similarly, no association 
was found between stress and antibody response to a thymus-independent pneumonia 
vaccination in pre-school children (68).  However, as older care-givers have been reported to 
show poorer maintenance of antibody levels over time following pneumonia vaccination than 
controls (41), it is possible that other factors such as age and severity of stress may interact to 




It should be noted that in the study of caregivers and the pneumonia vaccination, perceived stress 
did not differ between the caregiver and controls, but there was a significant difference in social 
support.  This might suggest that thymus-dependent vaccinations are susceptible to the effects of 
stressful life events, but that thymus-independent vaccinations are more vulnerable to other 
psychosocial factors such as lower social support.  There is some evidence for this suggestion.  
In our own laboratory, we found that social support, but not life events stress, was positively 
associated with the response to a thymus-independent pneumococcal vaccine in young healthy 
students (65,69). 
 
The comparison between thymus-dependent and –independent vaccination responses suggest 
that both types of response are susceptible to psychosocial influence, but that there are key 
variables which influence whether an effect on vaccination response is observed.  These include: 
the type of psychosocial factor studied (i.e. stress versus social support), and the age of the 
population sampled.   
 
4.4 Acute versus chronic stress 
Following on from the discussion above in section 4.1 regarding when stress is measured, such 
that moderate or less severe stress at the time of vaccination might actually have a beneficial 
effect, it has been suggested in recent years that acute (minutes or hours) stress may be immune 
enhancing when experienced close to the immune challenge.  Such immune enhancement by 
 
 
acute stress would be an adaptive mechanism, and might be regarded as an integral component of 
the fight or flight response, and circumstances that elicit such a response are likely to also 
involve exposure to antigens and, therefore, a robust immune response would be adaptive for 
survival (63).  Our laboratory examined the effect of acute psychological stress on antibody 
response to vaccination in humans.  Participants completed a 45 min time pressured, socially 
evaluated mental arithmetic task, or a resting control period, immediately prior to influenza 
vaccination.  An enhancement of the antibody response to one of the influenza viral strains was 
found in women in the psychological stress group compared to control (70).  Similarly, in men, 
the antibody response to a meningococcal A vaccination was enhanced by acute psychological 
stress (71).  That these effects emerged for only one gender or the other in these studies might be 
explained by examining the antibody responses for each gender.  In each case, stress was 
associated with the antibody response in those with the poorest increase in antibodies in response 
to vaccination; women for the influenza A/Panama strain and men for the meningococcal A 
vaccine.  This latter study (71) also provides further evidence that both thymus-dependent and –
independent vaccinations are responsive to the impact of stress, as discussed above.  Further, 
although not a psychological stressor per se, acute eccentric exercise (arm contractions) was also 
shown to enhance the antibody response to influenza vaccination in women, and the cell-
mediated IFNγ production response to stimulation with the influenza vaccine in men (72).  This 
and similar studies have also lent weight to the contention that effects of behavioural factors on 
vaccination responses are most likely to be observed in groups with the poorest antibody 
response, or to vaccine strains which are not very immunogenic i.e. they engender lower 




4.5 Timing of vaccination 
As well as the timing and duration of stress measurements associated with the vaccine response, 
other behavioural factors have been found to impact upon the antibody response.  One such 
factor is that of the time of day of vaccination.  In our study of the effects of psychological stress 
on vaccination responses in the 184 older adults (38), we observed that the time of day of 
vaccine administration significantly influenced antibody titre (74).  Men responded better in the 
morning than the afternoon; 41% of men showed a two-fold response when vaccinated in the 
morning versus 24% of men vaccinated in the afternoon.  This effect was independent of current 
illnesses, medication, vaccination history, and our reported findings of the effects of 
bereavement and marital quality.  Women tended to show the reverse pattern.  We also observed 
the same pattern in a study of younger adults’ antibody response to the hepatitis A vaccination 
(74).  However, these studies were not fully randomised, and there was little opportunity to 
examine the biological mechanisms, such as cytokine and stress hormone levels.  Consequently, 
there was a clear and pressing need for a randomised controlled trial of the impact of time of 
influenza vaccination on antibody response and vaccine efficacy in older adults in an National 
Health Service (NHS) setting.  We were able to conduct such a cluster-randomised trial within 
the National Health Service in Birmingham, UK, and confirmed that a simple manipulation of 
the time of vaccination can improve the immune response against influenza in older adults.  Two 
hundred and seventy-six participants were randomized to have the annual influenza vaccination 
at one of 24 General Practice surgeries in either the morning (9-11am) or afternoon (3-5pm).   
This trial provided some evidence that morning vaccination produced higher antibody levels, at 
least for the H1N1 A-strain with a trend for the same effect for the B influenza strain (75,76).  
Consequently, although this requires a larger scale trial for confirmation, we believe that 
 
 
morning vaccination could be employed as an easy to adopt intervention within the health 
services, at little or no added cost.  The potential benefits would be a decreased incidence of 
influenza infection and influenza-related mortality in older adults; although a multi-center very 
large trial following up on verified influenza incidence and health outcomes would be essential 
to fully prove this.   
 
5. Other psychosocial factors and the vaccination model 
5.1 Social support  
The support of friends and loved ones is an important determinant of immune health, and is 
relatively easily measured in vaccination studies via validated questionnaires.  Studies have 
assessed both functional social support, a measure of the quality and availability of social 
resources a person has, and structural social support, the number of friends a person can call on, 
in the context of vaccination.  First, students reporting greater social support demonstrated a 
stronger combined immune response to the third inoculation of the three-dose hepatitis B 
vaccination (40).  Second, loneliness and smaller social network size were associated with a 
poorer antibody response to the A/New Caledonian strain of the influenza vaccination in college 
students (77).  Third, students with greater functional social support showed higher titres to the 
A/Panama influenza strain at both five weeks and five months following vaccination (36).  In 
older nursing home residents, social support was also negatively correlated with pre- and post-
vaccination titres against the A/Panama influenza strain yet positively with pre-vaccination 
antibody titres against the A/New Caledonia strain (30), a finding which even the authors were 
unable to explain.  Along with the caregiver study discussed above, these studies generally show 
 
 
that a lack of social support has a strong negative impact on antibody levels following 
vaccination. 
 
Marriage is also a source of social support.  In our own work, older adults who were married, 
and particularly those who were happily married, showed a better antibody response to the 
influenza vaccination than those who were unmarried or less happily married (38).  However, 
more general functional social support and social network size was not associated with antibody 
response in this older population (38).  Further, for children, the relationship with their parents is 
the key source of support, and negative parent-child interactions such as conflict have been 
associated with a less robust antibody response to the meningococcal C vaccination over six 
months (78).  These findings perhaps lend weight to the suggestion that the age of the population 
studied influences which psychosocial factors are important for the vaccination response.   
 
5.2 Personality 
Personality factors, although often examined in the context of health outcomes, again using 
validated questionnaires (see e.g., (79), have scarcely been investigated relative to the 
vaccination response.  First, among a group of 12-year old girls,  those characterized by higher 
internalizing scores and lower self-esteem at baseline exhibited lower antibody titres following 
rubella vaccination (80).  A similar concept, neuroticism, was negatively associated with both the 
peak antibody response to the A/Panama strain of an influenza vaccination, and the maintenance 
of antibody titres to this strain in students (81).  Among female graduate students, trait negative 
affect/mood was negatively associated with the antibody response to the second hepatitis B 
injection (61).  Further, independently of negative affect, trait positive affect was associated with 
 
 
a better antibody response following a second hepatitis B vaccination in graduate students (82).  
Thus, both negative and positive traits appear to be able to influence this aspect of immune 
function and disease protection.  However, in exercising and sedentary elderly individuals, 
dispositional optimism was not found to be associated with antibody titres following influenza 
vaccination (83).  Inconsistencies in these results could be attributable to the different measures 
of personality studied, or the different ages of the populations used, which will now be discussed 
in more detail.   
 
6. Future directions: mechanisms and interventions 
The studies reviewed above outline the different methods of examining associations between 
psychological factors and the antibody response to vaccination.  These studies show the strong 
associations between psychological stress, other psychosocial factors and the immune response 
to vaccination, such that stressful psychological circumstances are associated with poorer 
antibody responses, while positive factors such as social support relate to a better immune 
response to vaccination.  Taken together, these findings suggest two main directions for future 
research.  First, despite the range of vaccinations used in such studies, as yet little is known about 
the exact mechanisms by which stress and other factors can influence antibody responses to 
vaccination.  Research incorporating a range of measurements, such as stress hormones, immune 
system messengers (cytokines), and the function of key cells in the vaccination response, such as 
antigen presenting cells, would be necessary to further our understanding regarding exactly how 
stress gets inside the body to affect this clinically relevant immune outcome.  Second, the clinical 
implications, in terms of susceptibility to disease, arising from a better understanding of the 
 
 
relationships between psychological factors and the vaccination response are important, 
particularly in the context of older adults who already display poor vaccination responses.  
Psychological interventions to improve vaccination response in these populations could include 
techniques such as stress management, relaxation, cognitive behavioural therapy, and emotional 
disclosure.   
 
Regarding such interventions, one study showed an improvement in the ability of older 
caregivers for a spouse with dementia to mount a four-fold increase in antibody titre following 
influenza vaccination relative to matched controls, although the mechanisms of effect were 
unclear and the intervention group was not randomly sampled (84).  Similarly, participants 
taking part in a written emotional disclosure intervention, where they wrote about their emotions 
about a previously undisclosed stressful event, showed significantly higher antibody titres at four 
and six months following vaccination with hepatitis B compared to a control non-intervention 
group (64).  A different clinical application of the vaccination model has arisen from the positive 
immune effects demonstrated in response to acute stress and exercise, as discussed above (70).  
These preliminary findings suggest that the development of such a behavioural challenge that 
could be applied in General Practitioner settings could be a way forward for improving the 
vaccination response.  This would be particularly important for groups at risk of infectious 
disease such as older adults, the bereaved, and care-givers.  At this stage, more work is required 
to establish exactly what types of intervention in which age groups and are likely to be the most 
beneficial for psychological, and hence immunological, health.  Behavioural interventions, such 





In conclusion, vaccination has had a substantial impact on public health, although not everyone 
mounts a satisfactory and protective antibody response to vaccination.  This increasingly appears 
to be the case with progressing age.  Studying antibody responses to vaccination is now 
contributing to the understanding of how psychosocial exposures can influence immunity and, 
consequently, resistance to disease.  The current challenges are to build upon the methodology 
that has been developed through these studies to unravel the underlying mechanisms and to 
develop and apply feasible behavioural interventions to boost the response to vaccination and, 
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